Antibodies to Bartonella species in inner-city intravenous drug users in Baltimore, Md

Archives of Internal Medicine

Volumn 156, Issue 21, 1996, Pages 2491-2495

  Comer, James A ^a,c   Flynn, Colin ^b   Regnery, Russell L ^a   Vlahov, David ^b   Childs, James E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CD4 ANTIGEN;

ADULT; ANTIBODY TITER; ARTICLE; BARTONELLA HENSELAE; BARTONELLA QUINTANA; BARTONELLACEAE; CONTROLLED STUDY; DISEASE TRANSMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; UNITED STATES;

ADULT; ANTIBODIES, BACTERIAL; BALTIMORE; BARTONELLA; FEMALE; HIV SEROPOSITIVITY; HUMANS; LOGISTIC MODELS; MALE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; URBAN HEALTH;

EID: 0029842670     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.21.2491     Document Type: Article

References (29)

1. Spach DH, Kanter AS, Dougherty MJ, et al. Bartonella (Rochalimaea) quintana bacteremia in inner-city patients with chronic alcoholism. N Engl J Med. 1995; 332:424-428.
2. Drancourt M, Mainardi JL, Brouqui P, et al. Bartonella (Rochalimaea) quintana endocarditis in three homeless men. N Engl J Med. 1995:332:419-423.
3. Regnery RL, Anderson BE, Clarridge JE III, Rodriguez-Barradas MC, Jones DC, Carr JH. Characterization of a novel Rochalimaea species, R henselae, sp nov, isolated from blood of a febrile, human immunodeficiency virus-positive patient. J Clin Microbiol. 1992;30:265-274.
4. Slater LN, Welch DF, Hensel D, Coody DW. A newly recognized fastidious gramnegative pathogen as a cause of fever and bacteremia. N Engl J Med. 1990; 323:1587-1593.
5. Slater LN, Welch DF, Min KW. Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatitis. Arch Intern Med. 1992;152:602-606.
6. Koehler JE, Quinn FD, Berger TG, LeBoit PE, Tappero JW. Isolation of Rochalimaea species from cutaneous and osseous lesions of bacillary angiomatosis. N Engl J Med. 1992;327:1625-1631.
7. Schwartzman WA, Patnaik P, Barka NE, Peter JB. Rochalimaea antibodies in HIV-associated neurologic disease. Neurology. 1994;44:1312-1316.
8. Tappero JW, Koehler JE, Berger TG, et al. Bacillary angiomatosis and bacillary splenitis in immunocompetent adults. Ann Intern Med 1993;118:363-365.
9. Welch DF, Pickett DA, Slater LN, Steigerwalt AG, Brenner DJ. Rochalimaea henselae, sp nov, a cause of septicemia, bacillary angiomatosis, and parenchymal bacillary peliosis. J Clin Microbiol. 1992;30:275-280.
10. Anderson B, Kelley C, Threlkel R, Edwards K. Detection of Rochalimaea henselae in cat scratch disease skin test antigens. J Infect Dis. 1993;168:1034-1036.
11. Anderson B, Sims K, Regnery R, et al. Detection of Rochalimaea henselae DNA in specimens from cat scratch disease patients by PCR. J Clin Microbiol. 1994; 32:942-948.
12. Regnery R, Tappero J. Unraveling mysteries associated with cat-scratch disease, bacillary angiomatosis, and related syndromes. Emerging Infect Dis. 1995; 1:16-21.
13. Regnery RL, Olson JG, Perkins BA, Bibb W. Serological response to 'Rochalimaea henselae' antigen in suspected cat scratch disease. Lancet. 1992; 339:1443-1445.
14. Daly JS, Worthington MG, Brenner DJ, et al. Rochalimaea elizabethae sp nov isolated from a patient with endocarditis. J Clin Microbiol. 1993;31:872-881.
15. Vlahov D, Anthony CJ, Munoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. NIDA Res Monogr. 1991;109:75-100.
16. Dalton MJ, Robinson LE, Cooper J, Regnery RL, Olson JG, Childs JE. Use of Bartonella antigens for serologic diagnosis of cat-scratch disease at a national referral center. Arch Intern Med. 1995;155:1670-1676.
17. Jackson LA, Spach DH, Kippen DA, et al. Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle. J Infect Dis. 1996;173:1023-1026.
18. Zangwill KM, Hamilton, DH, Perkins BA, et al. Cat scratch disease in Connecticut: epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med. 1993;329:8-13.
19. Childs JE, Rooney JA, Cooper JL, Olson JG, Regnery RL. Epidemiologic observations on infection with Rochalimaea species among cats living in Baltimore, Md. J Am Vet Med Assoc. 1994;204:1775-1778.
20. Koehler JE, Glasser CA, Tappero JW. Rochalimaea henselae infection: a new zoonosis with the domestic cat as reservoir. JAMA. 1994;271:531-535.
21. Regnery R, Martin M, Olson J. Naturally occurring 'Rochalimaea henselae' infection in domestic cat. Lancet. 1992;340:557-558.
22. Strong RP, ed. Trench Fever: Report of Commission, Medical Research Committee, American Red Cross. New York, NY: Oxford University Press Inc; 1918: 40-60.
23. Margileth AM. Cat scratch disease. Adv Pediatr Infect Dis. 1993;8:1-21.
24. Spach DH, Calis KP, Paauw DS, et al. Endocarditis caused by Rochalimaea quintana in a patient infected with human immunodeficiency virus. J Clin Microbiol. 1993;31:692-694.
25. Hadfield TL, Warren R, Kass M, Brun E, Levy C. Endocarditis caused by Rochalimaea henselae. Hum Pathol. 1993;34:1140-1141.
26. Spach DH, Kanter AS, Daniels NA, et al. Bartonella (Rochalimaea) species as a cause of apparent 'culture-negative' endocarditis. Clin Infect Dis 1995;20: 1044-1047.
27. Mascart-Lemone F, Gérard M, Libin M, et al. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody response to pneumococcal vaccine. J Infect Dis. 1995;172:1253-1260.
28. Müller F, Froland SS, Brandtzaeg P. Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV). Clin Exp Immunol. 1989;78:153-158.
29. Tausk PA, McCutchan JA, Spechko P, Schreiber RD, Gigli I. Altered erythrocyte C3b receptor expression, immune complexes, and complement activation in homosexual men in varying risk groups for acquired immune deficiency syndrome. J Clin Invest. 1986;78:977-982.